Investor optimism surges as LakeShore Biopharma reaffirms FY2025 guidance

LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) shares experienced a significant surge following the company's announcement that it would maintain its fiscal year 2025 (FY2025) guidance ... Read More